VYNDAMAX® (tafamidis) PBS-listed for adult patients with wild-type or hereditary transthyretin amyloid cardiomyopathy (ATTR-CM) with New York Heart Association (NYHA) Class I-II heart failure May 4, 2024 — 18:00
Integrated cancer biotech Infinitopes secures £12.8m seed financing to enhance its Precision Immunomics™ antigen discovery technologies to target five more cancers May 2, 2024 — 07:01
Clover Announces Positive Phase Ⅰ Results for SCB-219M for Treatment of Chemotherapy-Induced Thrombocytopenia (CIT) December 29, 2023 — 07:30
Kexing Biopharm Makes it into China’s Top 20 Biopharmaceutical Enterprises (Blood Products, Vaccines and Insulin) for Two Consecutive Years July 7, 2023 — 19:43
AFTER FIVE YEARS OF SUCCESSFUL EXPERIENCE INTERNATIONALLY, BIOCON BIOLOGICS’ HULIO® BIOSIMILAR TO HUMIRA®, NOW AVAILABLE IN THE UNITED STATES July 4, 2023 — 01:22
Brii Bio Announces New Data from Partners Underscoring Potential for HBV Functional Cure at EASL™ Congress 2023 June 25, 2023 — 20:00
Chula’s Faculty of Veterinary Science Ranks 1st in Thailand, TOP 10 in Asia, and Top 53 in the World in the 2023 Scimago Institutions Rankings June 23, 2023 — 10:00
True stories of Overseas Filipinos shine in global spotlight, in time for PH Independence Day June 10, 2023 — 11:02
The First of Its Kind in the World: The Recombinant Multivalent COVID-19 Protein Vaccine against XBB Variants by WestVac Biopharma/West China Medical Center, Sichuan University has been Approved for Clinical Trials by The National Medical Products Administration of China. May 18, 2023 — 21:23
Access to Novavax’s COVID Vaccine Grows with Extended Interim Authorization for Adolescents in Singapore May 12, 2023 — 21:01
Fosun Pharma Participates in BEYOND Expo 2023 to Showcase Its Innovative R&D Achievements May 10, 2023 — 22:57
OncoVent, a Subsidiary of Hepalink, Enters into a License and Distribution Agreement with Orient EuroPharma for the Immunotherapeutic Candidate Oregovomab March 28, 2023 — 15:36
Completion Of The First Batch Of Subject Enrollment For The Phase I Clinical Trial Of The Company’s Novel Adjuvanted Recombinant Shingles Vaccine REC610 February 13, 2023 — 15:02
GC Biopharma Receives WHO Pre-Qualification for Filling and Finish Plant in Ochang, South Korea February 9, 2023 — 09:21
Save On Beautiful Valentine’s Day Flowers from UFLOWERSHOP.COM With Discount Code February 3, 2023 — 21:50
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs January 27, 2023 — 20:00
CGTN: Xi Jinping salutes ordinary people’s extraordinary efforts in New Year Address January 3, 2023 — 07:52
GenScript ProBio Enters Strategic Collaboration with Hibiocy Co. Ltd, the affiliate of Rojukiss International Public Company Limited (KISS) – the leading Thai-based Beauty & Health company, for the development and manufacturing of COVITRAP™ and future new products. October 17, 2022 — 23:56
Hayashibara Brings Back "Trehalose Symposium" to Reveal Its Game-changing Versatilities in Human Biochemistry October 4, 2022 — 14:00
Qilian International Holding Group Limited Reports Financial Results for the First Six Months of Fiscal Year 2022 October 1, 2022 — 04:30
YishengBio Received Approvals From Philippines and UAE For Phase 2 / 3 Clinical Trials of PIKA Recombinant COVID-19 vaccine September 8, 2022 — 21:33
